Cargando…
非小细胞肺癌的驱动基因及其临床意义
With the development of molecular biology technology and the transforming patterns of drug research, guiding molecular targeted therapy according to the drive gene mutation spectrum in lung cancer has gradually become a reality. Definition of the mutation incidence and whether existing advantage pop...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000100/ https://www.ncbi.nlm.nih.gov/pubmed/24949689 http://dx.doi.org/10.3779/j.issn.1009-3419.2014.06.08 |